MXPA03007613A - Composiciones y metodos de fabricacion para formas de dosis oral disolubles. - Google Patents

Composiciones y metodos de fabricacion para formas de dosis oral disolubles.

Info

Publication number
MXPA03007613A
MXPA03007613A MXPA03007613A MXPA03007613A MXPA03007613A MX PA03007613 A MXPA03007613 A MX PA03007613A MX PA03007613 A MXPA03007613 A MX PA03007613A MX PA03007613 A MXPA03007613 A MX PA03007613A MX PA03007613 A MXPA03007613 A MX PA03007613A
Authority
MX
Mexico
Prior art keywords
compositions
manufacture
methods
dosage forms
oral dissolvable
Prior art date
Application number
MXPA03007613A
Other languages
English (en)
Inventor
Dennis L Coleman
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of MXPA03007613A publication Critical patent/MXPA03007613A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA03007613A 2001-02-27 2002-02-27 Composiciones y metodos de fabricacion para formas de dosis oral disolubles. MXPA03007613A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/798,027 US20020160043A1 (en) 2001-02-27 2001-02-27 Compositions and method of manufacture for oral dissolvable dosage forms
PCT/US2002/005851 WO2002067903A2 (en) 2001-02-27 2002-02-27 Compositions and methods of manufacture for oral dissolvable dosage forms

Publications (1)

Publication Number Publication Date
MXPA03007613A true MXPA03007613A (es) 2003-12-04

Family

ID=25172349

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007613A MXPA03007613A (es) 2001-02-27 2002-02-27 Composiciones y metodos de fabricacion para formas de dosis oral disolubles.

Country Status (6)

Country Link
US (1) US20020160043A1 (es)
EP (1) EP1385484A2 (es)
JP (1) JP2004520410A (es)
CA (1) CA2439376A1 (es)
MX (1) MXPA03007613A (es)
WO (1) WO2002067903A2 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7083578B2 (en) * 2001-07-12 2006-08-01 Given Imaging Ltd. Device and method for examining a body lumen
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
EP1539069A4 (en) * 2002-05-31 2007-11-14 Univ Mississippi TRANSMUCOSAL DELIVERY OF CANNABINOIDS
EP1610681B1 (en) * 2003-01-23 2011-10-05 University of Florida Research Foundation, Incorporated Method and apparatus for monitoring intravenous (iv) drug concentration using exhaled breath
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
US20060062812A1 (en) * 2003-03-11 2006-03-23 Calvin Ross Novel compositions
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US20050042281A1 (en) * 2003-08-21 2005-02-24 Singh Nikhilesh N. Compositions for delivering therapeutic agents across the oral mucosa
US20050142192A1 (en) * 2003-10-15 2005-06-30 Wyeth Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives
US7658945B2 (en) * 2004-02-17 2010-02-09 Transcept Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
EP1968539A2 (en) * 2005-12-13 2008-09-17 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US9066847B2 (en) * 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US20070260491A1 (en) * 2006-05-08 2007-11-08 Pamela Palmer System for delivery and monitoring of administration of controlled substances
US20070299687A1 (en) * 2006-06-23 2007-12-27 Pamela Palmer Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
EP3067044B1 (en) 2006-07-21 2019-03-27 BioDelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
CA2677281C (en) * 2007-02-09 2019-10-29 Durect Corporation Transoral dosage forms comprising sufentanil and naloxone
KR101606944B1 (ko) * 2007-08-07 2016-03-28 아셀알엑스 파마슈티컬스 인코퍼레이티드 경구 경점막 투여형을 사용한 시술시 진정과 무통을 위한 조성물 및 방법
BRPI0910094B1 (pt) 2008-03-26 2021-08-10 Stichting Sanammad Composição de goma de mascar, e, blíster
US20090312627A1 (en) * 2008-06-16 2009-12-17 Matott Laura A Radio-labeled ingestible capsule
US8945592B2 (en) 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
CN102448451A (zh) 2009-05-29 2012-05-09 森下仁丹株式会社 口腔用药剂组合物及封入了其的口腔用药剂胶囊
WO2011079050A2 (en) 2009-12-23 2011-06-30 The Smart Pill Corporation Method of evaluating constipation using an ingestible capsule
AU2012296346A1 (en) 2011-08-18 2014-04-03 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
AU2012311293B2 (en) 2011-09-19 2014-02-20 Orexo Ab New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
PE20142444A1 (es) 2012-05-02 2015-01-09 Orexo Ab Nueva composicion de alfentanilo para el tratamiento del dolor agudo
JP2016531913A (ja) * 2013-08-26 2016-10-13 アモーサ セラピューティックス， インコーポレイテッドＡｍｏｒｓａ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 神経抑制性ケタミンの単層による経口投与
WO2015051259A1 (en) * 2013-10-04 2015-04-09 Impax Laboratories, Inc. Pharmaceutical compositions and methods of use
AU2015369710B2 (en) 2014-12-23 2020-09-17 Vertical Pharmaceuticals, Llc Systems, devices and methods for dispensing oral transmucosal dosage forms
CA2981772C (en) 2016-02-11 2018-12-18 Gelpell Ag Oral solid cannabinoid formulations, methods for producing and using thereof
US20180110730A1 (en) * 2016-10-20 2018-04-26 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and opioid agonists and/or antagonists
EP3641726A1 (en) 2017-06-23 2020-04-29 MedCan Pharma A/S Cannabinoid pouch

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
GB9904911D0 (en) * 1999-03-03 1999-04-28 Scherer Ltd R P Pharmaceutical compositions
US20070104763A1 (en) * 2005-11-10 2007-05-10 Navinta Llc Composition of fentanyl citrate oral solid transmucosal dosage form, excipient and binding material therefore, and methods of making

Also Published As

Publication number Publication date
US20020160043A1 (en) 2002-10-31
JP2004520410A (ja) 2004-07-08
WO2002067903A2 (en) 2002-09-06
CA2439376A1 (en) 2002-09-06
EP1385484A2 (en) 2004-02-04
WO2002067903A3 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
MXPA03007613A (es) Composiciones y metodos de fabricacion para formas de dosis oral disolubles.
EP1372392A4 (en) ORAL DOSAGE FORM CONTAINING NICOTINE
PL356358A1 (en) Solid dosage form of someticone for oral administration
EP1383518A4 (en) ORAL DELIVERY OF MACROMOLECULES
PL367180A1 (en) Stabilized oral pharmaceutical composition
MXPA03008497A (es) Composiciones y kits para el cuidado oral.
PL365518A1 (en) Oral composition
EP1401500A4 (en) NUCLEOTIDE COMPOUNDS THAT BLOCK THE BITTER FLAVOR OF ORAL COMPOSITIONS
IL169902A0 (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
AU2002367019A8 (en) Process of making dental restorations
HUP0204229A3 (en) Compositions oral opioid formulations, compositions process for their preparation and their use
EP1553925A4 (en) ORAL DOSAGE FORM WITH MODIFIED RELEASE
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
AU2002320057A1 (en) Herbal composition for improving oral hygiene, and methods of using same
HUP0400850A3 (en) Oral pharmaceutical compositions
AU2003238670A8 (en) Fast disintegrating oral dosage forms
IL166337A0 (en) Oral administration of calctionin
PL369102A1 (en) Set of teeth
SG116507A1 (en) Pharmaceutical dosage form and method of making.
HUP0500638A3 (en) Flashmelt oral dosage formulation
GB0126244D0 (en) Oral compositions
EP1413589A4 (en) ORAL POLYMERS AND ORAL COMPOSITIONS
GB0016067D0 (en) Oral compositions
HUP0401599A3 (en) Extended release oral dosage form
HK1071275A1 (en) Chewing gums and process for the manufacture thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal